Position in CRSP
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$13,353,325
-$3,368,635 QoQ
Shares Held
280,709
-12.0% QoQ
Ownership
0.291%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 92.9485695150494.ToString("F0")%
Shared 0.ToString("F0")%
None 7.0514304849506075.ToString("F0")%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Derivatives in CRSP
reported options exposure · as of Dec 31, 2025CallValue
$5,244
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. CRSP ranks #15 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in CRSP
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,353,325 | 280,709 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $16,721,960 | 318,878 | Shares | Defined | 2026-02-13 | |
| 2025-12-31 | $5,244 | 100 | Call | Defined | 2026-02-13 | |
| 2025-09-30 | $6,481 | 100 | Call | Defined | 2025-11-13 | |
| 2025-09-30 | $19,648,964 | 303,178 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,864 | 100 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $11,466,392 | 235,740 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,035,848 | 265,526 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $8,664,041 | 220,123 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $9,538,301 | 203,029 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $12,292,621 | 227,599 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $14,749,414 | 216,394 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $10,541,650 | 168,397 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $9,224,971 | 203,238 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $11,252,811 | 200,442 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $9,344,290 | 206,595 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,555,349 | 136,663 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $9,126,257 | 139,652 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,417,069 | 138,507 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $12,295,825 | 195,887 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $14,564,081 | 192,189 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $51,805,678 | 462,840 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $75,526,862 | 466,532 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $46,283,745 | 379,842 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $71,122,347 | 464,518 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $46,893,599 | 560,660 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $39,861,121 | 542,402 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $21,269,417 | 501,519 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||